Ultragenyx Pharmaceutical
RARE
RARE
254 hedge funds and large institutions have $7.73B invested in Ultragenyx Pharmaceutical in 2021 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 88 increasing their positions, 98 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
10% less repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 98
17% less capital invested
Capital invested by funds: $9.36B → $7.73B (-$1.63B)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
254
Holding in Top 10
–
Calls
$47.3M
Puts
$17.9M
Top Buyers
| 1 | +$164M | |
| 2 | +$59.6M | |
| 3 | +$51.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32.5M |
| 5 |
HM
HealthCor Management
New York
|
+$28.3M |
Top Sellers
| 1 | -$114M | |
| 2 | -$50.1M | |
| 3 | -$49.4M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$27.9M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$26.4M |